ABSTRACT. The present study aims to purify and characterize lectin from tartary buckwheat seeds and study its properties as well as biological activities to determine its possible biomedical applications in promoting maturation and proliferation of peripheral blood DCs derived from healthy donors and to study the effect of inducing apoptosis in human leukemia U937 cells. A novel tartary buckwheat lectin (TBL) protein, purified from tartary buckwheat seeds, showed a single band with a molecular mass of 65 kDa in SDS-PAGE. The purified TBL hemagglutinated both human and animal erythrocytes and showed preference for blood type O and the rabbit blood type. TBL is active at up to 60°C, and it is acid-and alkali-stable. TBL (25 μg/mL) combined with 5 x 10 -5 M rhIL-4 promotes maturation and proliferation of peripheral blood dendritic cells (DCs), which is stronger than that promoted by rhTNF-α (20 ng/mL). Exposure of DCs to 50 μg/ mL TBL for 48 h resulted in extensive upregulation of maturation (2015) markers CD83 and CD40. These TBL-DCs were capable of producing several pro-inflammatory cytokines such as interleukin-10 (IL-10) and interleukin-12 (IL-12). The results of the treatment of human leukemia U937 cells with TBL in doses of 12.5, 25, 50, and 100 μg/mL showed that tartary buckwheat-derived lectin induces apoptosis in a dosedependent manner. Our results encourage the use of tartary buckwheat and tartary buckwheat-derived lectins as immunopotentiating foods, targeted to strengthen immune responses and display a potential dietary supplement for cancer prevention.
INTRODUCTION
Lectins are a diverse group of proteins of non-immune origin that interact reversibly and specifically with carbohydrates. These proteins are widely distributed in animals and plants. Lectins exhibit a variety of biological activities, such as anti-insect (Hilder et al., 1995) , antifungal (Herre et al., 2004) , anticancer (Dhuna et al., 2005) , antiviral (Balzarini et al., 1992) , and immunomodulatory activity (Rubinstein et al., 2004) . They have various different functions in nature, the most important is information mediation in biological systems. Studies have shown that some plant lectins have several applications within the plant body, such as in pathogen defense mechanisms (Vandenborre et al., 2011) , or outside the body, such as drug delivery (Bies et al., 2004) , as well as a variety of diagnostic applications for a broad spectrum of diseases (Gemeiner et al., 2009 ). However, there are few reports on the function that promotes maturation and proliferation of dendritic cells (DCs) (Liu et al., 2011) , and further study on the function of lectin on immune cells is warranted.
Tartary buckwheat grain is commonly used in the diets in Eastern Asian countries as an important functional food source (Kawakmi et al., 1995) . Tartary buckwheat protein has high biological value due to a well-balanced amino acid composition and abundance of lysine and arginine. Previous studies have demonstrated that it has diverse pharmaceutical effects including antioxidant, immunoregulation, antihypertensive, hypolipidemic, and hypoglycemic activities (Tomotake et al., 2006; Cao et al., 2008) . Especially, they have been reported to have high immunoregulation activities, and as strong antioxidants they act as scavengers for a wide range of reactive oxygen species and inhibitors of lipid peroxidation (Fabjan et al., 2003; Fujital et al., 2003) . The immunoregulation activities of tartary buckwheat extract might be related to some functional proteins or flavonoids, although they remain largely unexplored (Jin and Wei, 2011) .
DCs are the most potent antigen-presenting cells that play an important role in initiating adaptive immune responses and inducing antigen-specific T-lymphocyte responses. Immature DCs can capture antigens very efficiently by phagocytosis (Svensson et al., 1997) , macropinocytosis, and endocytosis (Sallusto et al., 1995) through different cell surface molecules, e.g., Toll-like receptors (TLRs). The immunogenicity of DCs correlates with its functionally mature state, which is characterized by the increased expression and production of molecules involved in antigen processing and presentation and further interaction with T cells. Furthermore, the maturation process of DC can be induced by various cytokines (such as ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (1): 2162 -2175 LPS, TNF-α, IL-1β, CD40L). It is reported that mature DCs are critical for a potent immune response against cancer cells following chemotherapy and radiotherapy (Vicari et al., 2002; Tesniere et al., 2008) . DCs engulf apoptotic cancer cells through the recognition of apoptotic characteristics of tumor cells induced by treatment with anti-tumor agents such as mitoxantrone and doxorubicin, which can lead to maturation of DCs and a potent immune response in vivo (Obeid et al., 2007; Apetoh et al., 2008) .
The present study aims to purify and characterize lectin from tartary buckwheat seeds and study its properties as well as biological activities to determine its possible biomedical applications in promoting maturation and proliferation of peripheral blood DCs derived from healthy donors and to study the effect of inducing apoptosis in human leukemia U937 cells. It may also provide insights for possible cancer prevention and immunotherapy.
MATERIAL AND METHODS

Materials
Tartary buckwheat seeds were obtained from Shanxi Academy of Agricultural Sciences, China. A Resource™ Q (6.4 x 30 mm) anion exchange column and Superdex™ G75 10/300 GL gel filtration column were purchased from GE Healthcare (Uppsala, Sweden), RhIL-4 and GM-CSF were purchased from R&D Systems (Minneapolis, MN, USA), and fetal bovine serum (FBS) and cell medium RPMI1640 were sourced from Sigma-Aldrich Co., Ltd., (St. Louis, MO, USA). Mouse anti-human CD83-PE monoclonal antibody, mouse anti-human CD40-FITC monoclonal antibody, mouse anti-human CD1a-FITC monoclonal antibody, and mouse anti-human HLA-DR monoclonal antibody were all products of Beckman Coulter Inc. (Brea, CA, USA). All solvents used in high performance liquid chromatography were of chromatography grade, and all other reagents were of the highest purity available.
Extraction and purification of lectin from tartary buckwheat
Tartary buckwheat seeds were prepared according to the protocol described in Cui and Wang, 2012 . The seeds were ground and extracted in acetate buffer (ACE buffer, pH 5.0) at 4°C for 24 h and centrifuged at 10.000 g for 30 min at 4°C. Solid (NH4) 2 SO 4 was slowly added to the supernatant to 80% saturation and continuously stirred for 4 h. The precipitate was collected by centrifugation at 12,000 g (30 min; 4°C), and then re-dissolved in 20 mM Tris-HCl buffer (pH 7.0) and centrifuged at 10,000 g (30 min; 4°C). The clear supernatant was used to determine the protein content and hemagglutinating activity. Pure TBL was obtained in two chromatographic steps with Resource™ Q anion exchange column and Superdex™ 75 10/300 GL gel filtration column using an AKTA Purifier (GE Healthcare). The TBL protein concentration was determined according to the method described by Bradford (1976) with bovine serum albumin as a standard.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was performed according to the method of Laemmli (1970) using 12.5% separating and 4% stacking gel. The gels were stained with Coomassie Brilliant Blue R-250 (Pharmacia, Uppsala, Sweden). The molecular weight of individual protein bands was deter-mined using a GeneGenius densitometric imaging system (Syngene, Cambridge, UK) with protein standards.
Hemagglutinating activity assay of TBL
Serial two-fold dilutions of lectin solution (25 μL) in microtiter v-plates were prepared with different types of 2% red blood cell suspensions in saline, separately. The plates were incubated at room temperature until the red blood cells in the blank (with no protein sample added) had fully settled at the bottom of the well and appeared as red sediment. Formation of plaques of agglutinated red blood cells indicated hemagglutinating activity. Specific activity of TBL is reciprocal of the highest dilution of the protein sample inducing hemagglutination per milligram protein, expressed as 2 n (n is the last well of inducing hemagglutination) (Yagi et al., 2002) . All experiments were performed in accordance with the guidelines established by the National Institutes of Health for the care and use of laboratory animals and were approved by the Animal Care Committee of the Shanxi University, Taiyuan, China, and Chinese Academy of Medical Sciences, Beijing, China.
Temperature and pH stability on hemagglutinating activity of TBL
For the pH stability test, the TBL was dissolved in solutions at different pH values: pH 2.4-3.0 in solutions with HCl and pH 11.7-12.2 in solutions with NaOH. After incubation at room temperature for 30 min, the solutions were neutralized, and assay of hemagglutinating activity was performed as described above (Chan and Ng, 2013) . For the heat stability test, the TBL solutions were heated at different temperatures (25°C-80°C) for 30 min and immediately cooled on ice. Cooled solutions were then assayed for hemagglutinating activity (Nakagawa et al., 1996) .
Isolation of peripheral blood mononuclear cells (PBMCs)
The study was conducted according to the principles of the Declaration of Helsinki. All study participants provided written informed consent. Peripheral blood mononuclear cells were isolated by the density-gradient centrifugation method using Ficoll-Paque (Pharmacia Biotech, Stockholm, Sweden). The cells were washed twice with phosphate buffered saline (PBS), and then suspended in RPMI 1640 (Gibco Laboratories, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) (Hyclone, Oud-Beijerland, Netherlands), 2 mM glutamine (Sigma), 100 U/mL penicillin G (Sigma), and 100 μg/mL streptomycin (Sigma), and placed in 75-cm 2 flasks.
Generation of human monocyte-derived dendritic cells (MoDCs)
After 2 h of adherence of PBMCs to the flask and two PBS washes, the adherent cells were used for generation of MoDCs following the method described by Tsai et al. (2010) . The adherent cells were cultured in RPMI1640 medium supplemented with 1000 U/mL GM-CSF (Peprotech, Rocky Hill, NJ, USA) and 500 U/ml of IL-4 (Peprotech) for 7 days. Cultured cells were harvested as DCs and used for subsequent experiments.
TBL-induced PBMCs proliferation assay
TBL-induced PBMCs proliferation was measured with a cell counting kit (CCK-8 kit; Dojindo). PBMCs (5 x 10 3 cells/well) were plated on a 96-well plate and treated with TBL at the concentrations of 10, 12.5, 25, 50, and 200 μg/mL; each group was present in triplicate. The control group was prepared by adding equal number of PBMCs and equal volume of medium. Each day, aliquots of 100 μL of medium without serum and 10 μL of CCK-8 were mixed and added to each well. After incubation at 37°C for 4 h, the OD value was assessed by spectrophotometry at a wavelength of 570 nm.
Effect of TBL on the maturation of DCs
Immature DCs were harvested after 7 days of culture, and part of the cells were identified by the flow cytometry method. The rest were equally divided into two wells, DCs in the test group were treated with TBL at a final concentration of 50 μg/mL, while that in the control group were treated with rhTNF-α at a final concentration of 20 ng/mL, and the cells were cultured for 2 days until maturation. The number, growth, and morphological characteristics of DCs were observed every day using inverted phase contrast microscope (Olympus, Tokyo, Japan).
Flow cytometric analysis
Mature DCs from the test group and the control group were harvested for cell phenotype identification. The cells were incubated for 30 min with monoclonal antibodies against FITC-HLA-DR, APC-CD1α, PE-CyTM FITC-CD40, and PE-CD83. FITC-IgG1 and APC-Ig G2 were used for isotype controls. All samples were analyzed by an FC 500 Flow Cytometry system (Beckman Coulter, Brea, CA, USA), and results were expressed as mean fluorescence intensity values after subtracting the mean fluorescence intensity obtained with the control antibody.
Quantification of cytokine production
The enzyme-linked immunosorbent assay (ELISA kits, R&D Systems) was used to assay the protein levels of interleukin-12 (IL-12) and interleukin-10 (IL-10) in the cell culture supernatant according to the manufacturer protocol. DCs were activated with 50 μg/mL TBL or 20 ng/mL TNF-α. After 48 h of stimulation, cells were centrifuged and the supernatant was used for ELISA analysis. All samples were tested in triplicate for standard curves.
Mixed-lymphocyte reaction (MLR) assay
MoDCs were incubated for 48 h with TBL (50 μg/mL) or TNF-α (20 ng/mL). Mature MoDCs were harvested and then treated with Mitomycin C (MMC; Sigma) (50 μg/mL). CD3 + T cells were isolated from adult peripheral blood mononuclear cells using a CD3 + T cell isolation kit (MACS; Miltenyi Biotec Inc., Bergisch Gladbach, Germany). T cells (1 x 10 6 ) were added to the 96-well plate, and using immature DC as the control group and mature DC as the TBL-and rhTNF-α-induced groups, the DC cells were divided into sets of 0.5 x 10 3 , 2.5 x 10 3 , 5 x 10 3 , and 10 x 10 3 cultured with T cells, and they were co-cultured for 72 h. Lymphocyte activation marker of CD69 and BrdU were analyzed using flow cytometry, and the innate T lymphocyte activation rate was calculated.
Apoptosis studies of TBL on lymphoma cells
We validated any potential toxicity of the TBL used in our study by an FC 500 Flow Cytometry system (Beckman Coulter) using an Apoptosis Detection Kit (Sigma) according to the manufacturer protocol. U937 cells were seeded in RPMI-1640 containing 10% FBS and treated with 0 (control), 12.5, 25, 50, and 100 μg/mL TBL, and 50 μg/mL BSA for 48 h. The percentages of live cells, dead cells, and cells in the early apoptotic process were determined by staining with annexin V-FITC conjugate and propidium iodide.
Statistical analysis
The data were analyzed by one-way and two-way analysis of variance followed by the Newman-Keuls test when appropriate. Statistically significant difference between experimental groups was assessed by a two-tailed Student t-test. The results are reported as means ± SD. A P value of less than 0.05 was considered to be statistically significant.
RESULTS
BL properties and hemagglutination assay
Hemagglutinating activity was determined in elutions between 35.0 and 40.0 mL with 1 M NaCl using FPLC-gel filtration chromatography on AKTA purifier. Purified TBL appeared as a single band with an approximate molecular weight of 65 kDa in SDS-PAGE (Figure 1) . . TBL had moderate thermostability. It retained full hemagglutinating activity at temperatures up to 62°C, but the activity dropped abruptly when the temperature was elevated from 64°C to 70°C, and vanished at 80°C (Table 2) . On the other hand, TBL showed fairly high pH stability. Hemagglutinating activity was preserved at pH 2 to 13, while the activity was halved at pH 0 to 1 and completely eliminated at pH 14 (Table 3) .
Proliferation of PBMCs with various concentrations of TBL
During the 4 days of observations, there was no significant difference in the number of PBMCs between the group treated with TBL concentration of 50 μg/mL and the control group (Figure 2) , indicating that TBL has no adverse effect on the proliferation of PBMCs at the concentration of 50 μg/mL. Therefore, this concentration of TBL was chosen for co-culture with immature DCs. Initial concentration was 1 mg/mL, 2 8 = 3.91 µg/mL; 2 9 = 1.95 µg/mL; 2 10 = 0.97 µg/mL. Initial concentration was 1 mg/mL, 2 9 = 1.95 µg/mL; 2 10 = 0.97 µg/mL. 
Effect of TBL on DCs morphology
To investigate whether TBL induces peripheral blood (PB) DCs maturation, we observed the morphology of DCs under the inverted phase contrast microscope. Compared with the control group, the number of DCs after their incubation with 50 μg/mL TBL significantly increased, and with increased apophysis, these cells were irregular and presented the evidence of dendritic processes, which characterizes the typical maturation process in DCs ( Figure 3A and B) . 
TBL causes extensive upregulation of DC maturation markers
We measured the expression of PBDC maturation markers such as CD1α, HLA-DR, CD40, and CD83 using TNF-α as a positive control. Untreated PBDCs expressed basal levels of CD1α (88.7 ± 0.5%) and HLA-DR (91.5 ± 0.6%), indicated the high purity of DCs, but still in the immature phase, whereas the expression of CD40 and CD83 was low at 26.3 ± 0.7 and 28.4 ± 0.4% respectively. As we expected, the amount of CD83 (85.1 ± 0.7%) in TBL-treated group was higher than in PBDCs treated with TNF-α (56.4 ± 0.4%). These results indicate that 50 μg/mL TBL can upregulate the expression of CD83 (P < 0.05), a known marker of DC maturation, and thus promote the maturation of DCs in more effective way (Table 4) . Text group compared with control group, *significant difference at P < 0.05. The number of DCs in the test group was 5.8 x 10 5 ± 0.8 x 10 3 , and in the control group there were only 5.3 x 10 5 ± 1.1 x 10 3 .
Activation of DCs with TBL induces production of certain pro-inflammatory cytokines
DCs secrete various cytokines (IL-6, IL-10, IL-12, and TNF-α), which in turn induce numerous cellular and molecular events needed by various immune cells to elicit antigenspecific immune responses. ELISA was employed to detect the IL-12 and IL-10 content in the supernatant of DCs following 48-h-long maturation induction. The secretion of IL-10 and IL-12 stimulates the proliferation and differentiation of Th2 and Th1 cells, respectively (Trinchieri 2003 (Trinchieri , 2007 . The secretion of IL-10 and IL-12 in TBL-treated PBDCs was significantly increased in a dose-dependent manner ( Figure 4A and B) . 
PBDCs activated with TBL induce and promote T lymphocytes activation
Mature DCs demonstrate high expression of costimulatory molecules and are potent to activate and stimulate the proliferation of T lymphocytes (Li et al., 2012) . To characterize the effect of TBL-treated PBDCs on the interaction with T cells, we performed an allogeneic MLR assay using human CD3 + T cells. CD3 + T cells co-cultured with TBL-treated DCs proliferated to greater extent than CD3 + T cells co-cultured with TNF-α-treated DCs after 72-h incubation period. Using flow cytometry to analyze the lymphocyte activation markers CD69 and BrdU, we calculated the primary T lymphocyte activation rate ( Figure 5 ). We then investigated IFN-γ and IL-4 productions in CD3
+ T cells activated with TBL-treated PBDCs. CD3 + T cells primed with TBL-treated PBDCs produced significantly higher levels of IFN-γ than cells primed with untreated PBDCs (Figure 6A , B). 
TBL-treated U937 cells cause cells apoptosis
After we investigated the effect of TBL on normal cells, we decided to study how TBL affects tumor cells. For this purpose, we cultured U937 with various concentrations of TBL and 50 μg/mL BSA for 48 h. The addition of TBL at concentrations of 12.5 μg/mL and higher to U937 cell cultures significantly increased the number of dead or apoptotic cells compared with either non-treated or BSA-stimulated control U937 cells ( Figure 7A-F) . 
DISCUSSION
Tartary buckwheat-derived lectins are characterized by moderate thermo-and pH stability and exhibited agglutination toward four types of human erythrocytes and three types of animal erythrocytes. TBL retained its full hemagglutinating activity in the broad range of pH 2 to 13, while the activities of some other lectins were reported to diminish above pH 9 (Kaur et al., 2005; Vaz et al., 2010) .
In the present study, we evaluated the immunomodulatory effects of TBL, which exhibit both DC maturation-inducing activity and apoptosis-inducing activity on human leukemia U937 cells. At a concentration of 25 μg/mL, TBL induces functional maturation of DCs as well as the extensive phenotypic expression of DCs, which are subsequently capable of stimulating efficient T cell responses. Moreover, TBL can increase the cytokines of IL-12 and IL-10 production. IL-12 is a functional DC maturation marker and is involved in the differentiation of naïve T cells into Th1 cells (Kaliński et al., 1997) . IL-10 is a cytokine with pleiotropic effects in immunoregulation and inflammation, and it also has stimulatory effect toward Th2 cells and stimulates B cell maturation and antibody production. Production of cytokines such as IL-12 and IL-10 during the DCs maturation process can influence DC induction of the Th1 or Th2 immune response. Previous reports have shown the immunomodulatory effects of lectin on DCs. N-acetyl-d-galactosamine binding lectin from mistletoe (Viscum album) has also been shown to induce the maturation of DCs (Stein et al., 2002a,b) . A galactose-N-acetyld-galactosamine lectin (Gal-lectin) from Entamoeba histolytica has also been shown to induce maturation and activation of DCs as well as Th1 cytokine production (Ivory and Chadee, 2007) . Besides, Gal-lectin also activated macrophages in which lectin increased gene transcription and surface expression of TLR2 (Kammanadiminti et al., 2004) .
In addition to its DC maturation activity, tartary buckwheat-derived lectins also induce apoptosis in human leukemia U937 cells. Tumor is a disease state characterized by a loss of apoptosis. Apoptosis is the process of programmed cell death through a tightly controlled program that plays important roles in many normal processes (Reed, 2001) . Thus, application of TBL may represent a useful strategy to modulating apoptosis in the therapy or prevention and management of cancer, and it has been a new target for drug discovery based on innovative mechanism in apoptotic induction. Compounds that induce apoptosis to block or suppress the proliferation of tumor cells are considered to have potential as antitumor agents (Frankfurt and Krishan, 2003) . Further investigation of the immunopotentiating activity of tartary buckwheat-derived lectins in animal cancer models is warranted.
In summary, we purified lectin from tartary buckwheat and for the first time, characterized its notable biological properties such as maturation-inducing DCs and apoptosis-inducing human leukemia cells activities. These results provide an important basis for further studies on the pharmacological activity of tartary buckwheat and its components and the potential of TBL as an adjuvant in cancer prevention and immunotherapy.
